Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-U3350
Vagus Nerve Stimulation Market is poised to register a CAGR of 11.4% during the forecast period 2022 to 2028. Vagus nerve is a crucial part of the autonomic nervous systems that controls involuntary body functions like heart rate. It passes from the abdomen to the lower part of the brain via chest and neck. Vagus nerve stimulation therapy is developed to prevent seizures by consistently sending mild electrical pulses through the vagus nerve to the brain. The VNS device is referred as the ‘brain pacemaker’ and it is placed on the chest wall under the skin. The vagus nerve is connected to the device using a wire. Vagus nerve stimulators are used for curing treatment resistant depression and intractable epilepsy. The rising incidences of neurological disorders like epilepsy, obtaining efficient clinical outcomes using this technique are some crucial factors contributing to the vagus nerve stimulation market growth. Conversely, a lack of skilled healthcare professionals and step costs related with these devices shall restrain the market growth. On the other hand, rising research and development activities for expanding the range of applications of using neurostimulators shall provide substantial growth opportunities to the market. Market Segmentation: By Product • Implantable VNS Devices • External VNS Devices By Application • Depression • Epilepsy • Migraine By Biomaterial • Ceramics • Metallic • Polymerics By End User • Hospitals • Ambulatory Surgical Centers • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is classified into product, application, biomaterial, end user and region. The product segment is fragmented into implantable VNS devices and external VNS devices. The external VNS devices are predicted to hold the largest vagus nerve stimulation market share as the process of fitting this device is minimally invasive, which is highly preferred by patients and is also a cheaper alternative than an implantable VNS device. The application segment is categorised into depression, epilepsy and migraine. The depression segment is predicted to lead the market as VNS devices are primarily used for treating treatment resistant depression. The biomaterial segment is divided into ceramic, metallic and polymerics. The end user segment is categorised into hospitals, ambulatory surgical centres and others. The hospital segment is anticipated to dominate the market owing to advancements in the hospital infrastructure, rise in the number of multispecialty hospitals and rising patient population across the world. Regional Analysis: The North America region is predicted to dominate the market owing to a strong presence of key market players in the region. Furthermore, unprecedented advancements in the healthcare infrastructure in the region shall boost its market growth. Additionally, there has been a rising awareness amongst patients regarding neurological disorders and alternatives to treat them. Competitive Landscape: Some of the crucial market players are Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, NeuroPace Inc. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global vagus nerve stimulation market by product, by application, by biomaterial, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Vagus nerve is a crucial part of the autonomic nervous systems that controls involuntary body functions like heart rate. It passes from the abdomen to the lower part of the brain via chest and neck. Vagus nerve stimulation therapy is developed to prevent seizures by consistently sending mild electrical pulses through the vagus nerve to the brain. The VNS device is referred as the ‘brain pacemaker’ and it is placed on the chest wall under the skin. The vagus nerve is connected to the device using a wire. Vagus nerve stimulators are used for curing treatment resistant depression and intractable epilepsy. The rising incidences of neurological disorders like epilepsy, obtaining efficient clinical outcomes using this technique are some crucial factors contributing to the vagus nerve stimulation market growth. Conversely, a lack of skilled healthcare professionals and step costs related with these devices shall restrain the market growth. On the other hand, rising research and development activities for expanding the range of applications of using neurostimulators shall provide substantial growth opportunities to the market.
Market Segmentation:
By Product • Implantable VNS Devices • External VNS Devices By Application • Depression • Epilepsy • Migraine By Biomaterial • Ceramics • Metallic • Polymerics By End User • Hospitals • Ambulatory Surgical Centers • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is classified into product, application, biomaterial, end user and region. The product segment is fragmented into implantable VNS devices and external VNS devices. The external VNS devices are predicted to hold the largest vagus nerve stimulation market share as the process of fitting this device is minimally invasive, which is highly preferred by patients and is also a cheaper alternative than an implantable VNS device. The application segment is categorised into depression, epilepsy and migraine. The depression segment is predicted to lead the market as VNS devices are primarily used for treating treatment resistant depression. The biomaterial segment is divided into ceramic, metallic and polymerics. The end user segment is categorised into hospitals, ambulatory surgical centres and others. The hospital segment is anticipated to dominate the market owing to advancements in the hospital infrastructure, rise in the number of multispecialty hospitals and rising patient population across the world.
Regional Analysis:
The North America region is predicted to dominate the market owing to a strong presence of key market players in the region. Furthermore, unprecedented advancements in the healthcare infrastructure in the region shall boost its market growth. Additionally, there has been a rising awareness amongst patients regarding neurological disorders and alternatives to treat them.
Competitive Landscape:
Some of the crucial market players are Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, NeuroPace Inc.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global vagus nerve stimulation market by product, by application, by biomaterial, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Vagus Nerve Stimulations Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Vagus Nerve Stimulations Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Vagus Nerve Stimulations Market, By Product Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1 Implantable VNS Devices 7.2 External VNS Devices 8. Vagus Nerve Stimulations Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1 Depression 8.2 Epilepsy 8.3 Migraine 9. Vagus Nerve Stimulations Market, By Biomaterial Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1 Ceramics 9.2 Metallic 9.3 Polymerics 10. Vagus Nerve Stimulations Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 10.1 Hospitals 10.2 Ambulatory Surgical Centers 10.3 Others 11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020 11.2.1. U.S. 11.2.2. Canada 11.2.3. Mexico 11.2.4. Rest of North America 11.3 Market Size (USD Mn) Forecast for North America 2022-2028 12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4 Market Size (US$ Mn) Forecast for Latin America 2022-2028 13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5 Switzerland 13.2.6. Spain 13.2.7. Russia 13.2.8. Poland 13.2.9. Rest of Western Europe 13.3 Market Size (US$ Mn) Forecast for Europe 2022-2028 14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2016-2020 14.2.1 Japan 14.2.2 China 14.2.3 Singapore 14.2.4 Korea 14.2.5 India 14.2.6 Australia and New Zealand 14.2.7 ASEAN 14.2.8 Rest of Asia Pacific 14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3 Market Size (US$ Mn) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1 Medtronic Plc. 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 ElectroCore LLC 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 LivaNova Plc. 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 Boston Scientific Corporation 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 Aleva Neurotherapeutics SA 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 BioControl Medical 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 Bioness Inc. 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 EnteroMedics Inc. 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 Nevro Corporation 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10 NeuroPace Inc. 17.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics